Transcatheter structural heart therapies stand to replace their open-heart counterparts thanks to technological innovations and expanded patient access.
Decision expands access to TAVR by modernizing requirements providers must meet to perform the cardiac procedure under Coverage with Evidence Development (CED).
Using data from the Florida Cardiovascular Quality Network, researchers analyzed 254 patients who all had angina symptoms and presented for clinical evaluation.